DE60031518D1 - Methode zur Diagnostizierung, Prognose oder Evaluation von Behandlung der Depressionen, basiert auf erhöhte Neurotrophin Concentrationen in zerebrospinale Flüssigkeit. - Google Patents

Methode zur Diagnostizierung, Prognose oder Evaluation von Behandlung der Depressionen, basiert auf erhöhte Neurotrophin Concentrationen in zerebrospinale Flüssigkeit.

Info

Publication number
DE60031518D1
DE60031518D1 DE60031518T DE60031518T DE60031518D1 DE 60031518 D1 DE60031518 D1 DE 60031518D1 DE 60031518 T DE60031518 T DE 60031518T DE 60031518 T DE60031518 T DE 60031518T DE 60031518 D1 DE60031518 D1 DE 60031518D1
Authority
DE
Germany
Prior art keywords
depression
subject
prognosis
diagnosis
evaluation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60031518T
Other languages
English (en)
Other versions
DE60031518T2 (de
Inventor
Roger Nitsch
Christoph Hock
Uwe Otten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evotec OAI AG
Original Assignee
Evotec OAI AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP99108723A external-priority patent/EP1050758A1/de
Application filed by Evotec OAI AG filed Critical Evotec OAI AG
Application granted granted Critical
Publication of DE60031518D1 publication Critical patent/DE60031518D1/de
Publication of DE60031518T2 publication Critical patent/DE60031518T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G01N2800/304—Mood disorders, e.g. bipolar, depression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
  • Steroid Compounds (AREA)
DE60031518T 1999-05-03 2000-05-02 Verfahren zum Diagnostizieren oder Prognostizieren einer Depression oder zum Überwachen des Fortschritts oder zur Bewertung der Behandlung einer Depression auf der Basis von erhöhten Neurotrophin-3-Konzentrationen im Liquor Expired - Fee Related DE60031518T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP99108723A EP1050758A1 (de) 1999-05-03 1999-05-03 Methoden zur Diagnostizierung oder zur Behandlung von neuropsychiatrischen Erkrankungen, die auf erhöhten Neurotrophin 3-Spiegel basiert sind
EP99108723 1999-05-03
EP99120212 1999-10-09
EP99120212 1999-10-09
PCT/EP2000/003912 WO2000067032A1 (en) 1999-05-03 2000-05-02 Methods of diagnosing or treating depression

Publications (2)

Publication Number Publication Date
DE60031518D1 true DE60031518D1 (de) 2006-12-07
DE60031518T2 DE60031518T2 (de) 2007-08-30

Family

ID=26152989

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60031518T Expired - Fee Related DE60031518T2 (de) 1999-05-03 2000-05-02 Verfahren zum Diagnostizieren oder Prognostizieren einer Depression oder zum Überwachen des Fortschritts oder zur Bewertung der Behandlung einer Depression auf der Basis von erhöhten Neurotrophin-3-Konzentrationen im Liquor

Country Status (6)

Country Link
US (1) US20080188435A1 (de)
EP (1) EP1173768B1 (de)
AT (1) ATE343793T1 (de)
AU (1) AU4753800A (de)
DE (1) DE60031518T2 (de)
WO (1) WO2000067032A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6943479B2 (ja) * 2016-07-08 2021-09-29 バイオメリカ・インコーポレイテッドＢｉｏｍｅｒｉｃａ， Ｉｎｃ． うつ病感受性試験の組成物、デバイスおよび方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95511A (en) * 1989-08-30 2000-10-31 Max Planck Gesellschaft Neurotrophin-3 a novel neurotrophic factor related to nerve growth and brain derived neurotrophic factor
WO1993009798A1 (en) * 1991-11-12 1993-05-27 Regeneron Pharmaceuticals, Inc. Therapeutic and diagnostic methods based on tissue specific nt-3 expression and receptor binding
EP0666756B1 (de) * 1992-09-14 1999-11-24 Regeneron Pharmaceuticals, Inc. Methode zum erzeugen von analgie mittels neurotrophine
IL109280A0 (en) * 1993-04-15 1994-07-31 Regeneron Pharma Neurotrophins for treatment of depression

Also Published As

Publication number Publication date
WO2000067032A1 (en) 2000-11-09
ATE343793T1 (de) 2006-11-15
US20080188435A1 (en) 2008-08-07
EP1173768A1 (de) 2002-01-23
DE60031518T2 (de) 2007-08-30
AU4753800A (en) 2000-11-17
EP1173768B1 (de) 2006-10-25

Similar Documents

Publication Publication Date Title
ATE283487T1 (de) Verfahren zur diagnose oder prognose von altersbedingter maculadegeneration
DE60233485D1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
ATE419390T1 (de) Verfahren zur diagnose von bauchspeicheldrüsenkrebs
DE60331941D1 (de) Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiert
ATE546734T1 (de) Risikomarker für eine herzkreislaufkrankheit
ATE502119T1 (de) Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna
ATE423217T1 (de) Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten
RU2008103988A (ru) Способ диагностики рассеяного склероза
WO2006015874B1 (en) Method for diagnosing liver fibrosis
WO2003089897A3 (en) Diagnosis and treatment of vascular disease
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
WO2000018954A3 (en) Use of pex in the treatment of metabolic bone diseases
WO2007015113A3 (en) New protein isoforms of the pif-family and uses thereof
CN101173314B (zh) 检测老年黄斑变性疾病的试剂盒
ATE286253T1 (de) Methoden zur diagnose oder prognose der alzheimerschen krankheit
ATE126599T1 (de) Verfahren zur bestimmung von anti-rns- antikörpern.
DE60031518D1 (de) Methode zur Diagnostizierung, Prognose oder Evaluation von Behandlung der Depressionen, basiert auf erhöhte Neurotrophin Concentrationen in zerebrospinale Flüssigkeit.
ATE494556T1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
DE60033646D1 (de) Methoden zur diagnostizierung oder zur behandlung der alzheimer-krankheit
ATE225405T1 (de) Verfahren zur diagnose oder zur prognose von alzheimer krankheit: therapeutische zusammensetzung zur verhinderung oder zur behandlung von alzheimer krankheit
Botía et al. Gaining knowledge about biomarkers of the immune system and inflammation in the saliva of pigs: The case of myeloperoxidase, S100A12, and ITIH4
ATE499611T1 (de) Verfahren zur diagnose von erkrankungen unter bestimmung von apolipoprotein c-i
DE60238055D1 (de) Verfahren zur diagnose einer person mit multipler sklerose
ATE392622T1 (de) Verfahren zur diagnose von leberfibrose
DE602005023973D1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee